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Astrocytes, the most versatile cells of the central nervous system, play an important role in the regulation
of neurotransmitter homeostasis, energy metabolism, antioxidant defenses and the anti-inﬂammatory
response. Recently, our group characterized cortical astrocyte cultures from adult Wistar rats. In line
with that work, we studied glial function using an experimental in vitro model of aging astrocytes (30
days in vitro after reaching conﬂuence) from newborn (NB), adult (AD) and aged (AG) Wistar rats. We
evaluated metabolic parameters, such as the glucose uptake, glutamine synthetase (GS) activity, and
glutathione (GSH) content, as well as the GFAP, GLUT-1 and xCT expression. AD and AG astrocytes take up
less glucose than NB astrocytes and had decreased GLUT1 expression levels. Furthermore, AD and AG
astrocytes exhibited decreased GS activity compared to NB cells. Simultaneously, AD and AG astrocytes
showed an increase in GSH levels, along with an increase in xCT expression. NB, AD and AG astrocytes
presented similar morphology; however, differences in GFAP levels were observed. Taken together, these
results improve the knowledge of cerebral senescence and represent an innovative tool for brain studies
of aging.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
Astrocytes are robust glial cells that play several roles in central
nervous system (CNS) homeostasis. They are responsible for
neurotransmitter management, synaptic processing, ionic homeo-
stasis, antioxidant defenses and the anti-inﬂammatory response as
well as energy metabolism (Jiang and Cadenas, 2014; Maragakis
and Rothstein, 2006; Parpura et al., 2012; Perea et al., 2014;
Wang and Bordey, 2008). Their strategically positioned processes
are able to reach both blood capillaries and other cells, allowing
them to carry energy substrates that provide metabolic fuel for
brain activity (Belanger et al., 2011; Schousboe et al., 2011). These
functions can likely be attributed to an organized cytoskeleton,
which implicates the presence of characteristic intermediate ﬁla-
ments, such as glial ﬁbrillary acidic protein (GFAP), a classical
cytoskeletal marker of astrocytes. GFAP is thought to contribute to a
broad number of functions, such as mechanical strength and, Basic Health Sciences Insti-
legre, Ramiro Barcelos, 2600,astrocytic shape (Menet et al., 2001; Middeldorp and Hol, 2011).
Astrocytes are also known to be both highly oxidative and
glycolytic, and through glucose transporter 1 (GLUT 1), they are
able to transport glucose from the blood to the inside of the cell and
thereby provide metabolic fuel for the CNS (Benarroch, 2014;
Nedergaard et al., 2003). Moreover, astrocytes are critical cells in
glutamatergic transmission homeostasis. They take up glutamate
through their high-afﬁnity glutamate transporters GLT-1 and
GLAST (Anderson and Swanson, 2000; Benarroch, 2010; Danbolt,
2001; Ye and Sontheimer, 2002), which may then be used as a
substrate for oxidation in the tricarboxylic acids cycle, to synthesize
either the tripeptide glutathione (GSH), the major antioxidant of
the brain, or glutamine through glutamine synthetase (EC 6.3.1.2)
(Dringen, 2000; Uwechue et al., 2012; Mates et al., 2002; Lee et al.,
2010). Astrocytes are not only able to take up glutamate but also
able to release it in a non-vesicular manner through a cystine-
glutamate antiporter (system xc ), allowing it to activate extra-
synaptic receptors and shape synaptic activity. System xc is an
important source of cystine, which is intracellularly converted to
cysteine, the rate-limiting substrate in GSH biosynthesis (Lewerenz
et al., 2006; Sato et al., 1999).
Previous studies from our group have shown that adult and aged
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of astrocytes under physiological and pathological conditions
(Bellaver et al., 2014; Souza et al., 2013). Our culture model dem-
onstrates the correct functioning of various astrocytic features, such
as the expression of GFAP, and other proteins related to glial
function (GLT-1, GLAST, GS, S100B and vimentin), glutamate and
glucose uptake, antioxidant defenses and the release of inﬂam-
matorymediators. Furthermore, these cells have also demonstrated
age-related cellular alterations and responses to neurotoxic and
neuroprotective stimuli.
Considering the importance of the changes that brain undergo
during aging and the lack of models to better comprehend these
changes, the aim of this study was to evaluate glial parameters in
primary cortical cultures from newborn (NB), adult (AD) and aged
(AG) Wistar rats, 30 days after the cultures reached conﬂuence,
which is referred to in the text as aged in vitro (AIV). Thus, we
evaluated glucose uptake, GS activity and GSH content, as well as
cellular morphology, GFAP, GLUT-1 and xCT (a functional subunit of
system xc ).
2. Materials and methods
2.1. Reagents
Dulbecco's Modiﬁed Eagle's Medium/F12 (DMEM/F12) and
other materials for cell culture were purchased from Gibco/Invi-
trogen (Carlsbad, CA, USA). Papain was acquired from Merck
(Darmstadt, Germany). DNase, cysteine, albumin and monoclonal
anti-GAPDH were purchased from SigmaeAldrich (St. Louis, MO,
USA). 2-Deoxy-D-[1,2e3H]glucose ([3H]2DG), nitrocellulose mem-
brane and an ECL kit were purchased from Amersham (Buck-
inghamshire, UK). Polyclonal anti-GLUT1 and polyclonal anti-xCT
were acquired from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). All other chemicals were from common commercial
suppliers.
2.2. Animals
Male Wistar rats (1, 90 and 180 days old) were obtained from
our breeding colony (Department of Biochemistry, UFRGS, Brazil),
maintained under a controlled environment (12 h light/12 h dark
cycle; 22 ± 1 C; ad libitum access to food and water). All animal
experiments were performed in accordance with the NIH Guide for
the Care and Use of Laboratory Animals and were approved by the
Federal University of Rio Grande do Sul Animal Care and Use
Committee (process number 24419).
2.3. Cell culture obtainment and maintenance
Male Wistar rats (1, 90 and 180 days old) had their cerebral
cortices aseptically dissected and meninges removed. The tissue
was digested using trypsin only at 37 C, for newborns or using
trypsin and papain at 37 C for adult and aged rats as previously
described (Souza et al., 2013). After mechanical dissociation and
centrifugation, the cells were resuspended in DMEM/F12 [10% fetal
bovine serum (FBS), 15 mM HEPES, 14.3 mM NaHCO3, 1% Fungizone
and 0.04% gentamicin], plated on 6- or 24-well plates pre-coated
with poly-L-lysine and cultured at 37 C in a 5% CO2 incubator.
The cells were seeded at a density of 3e5  105 cells/cm2. Twenty
four hours later, we performed amedium exchange; during the ﬁrst
week, we replaced the medium once every two days and from the
2ndweek on, we replace it once every four days; at each medium
exchange we submit the cells to mechanical shaking, therefore,
depleting the cultures from microglial presence (data not shown).
At that time, the newborn cells reached conﬂuence. From the 3rdweek on, the adult and aged astrocytes received medium supple-
mented with 20% FBS until they reached conﬂuence (at approxi-
mately the 4th to 5th week). Experiments were performed thirty
days after the cultures reached conﬂuence. In order to maintain
cells in a naive state, no dibutyryl cAMP was added to the culture
medium.
2.4. Cell morphology
Morphological studies were performed using phase contrast
optics (Nikon inverted microscope).
2.5. Western blot analyses
Cells were solubilized in lyses solution containing 4% SDS, 2 mM
EDTA, 50mM TriseHCl (pH 6.8). Protein content was measured, the
samples were standardized in sample buffer [62.5 mM TriseHCl
(pH 6.8), 4% (v/v) glycerol, 0.002% (w/v) bromophenol blue] and
boiled at 95 C for 5 min. Samples were separated by SDS/PAGE
(45 mg protein per sample), and transferred to nitrocellulose
membranes. Adequate loading of each sample was conﬁrmed using
Ponceau S staining. Membranes were incubated overnight (4 C)
with one of the following antibodies: anti-GFAP (1:1000), anti-
GLUT-1 (1:100), anti-xCT (1:100) or anti-GAPDH (1:3000). Then,
the membranes were washed and incubated with a peroxidase-
conjugated anti-rabbit immunoglobulin (IgG) (for anti-GFAP, anti-
GLUT-1 and anti-xCT) or with peroxidase-conjugated anti-mouse
IgG (for anti-GAPDH) at a dilution of 1:3000 for 2 h at room tem-
perature. Chemiluminescence signals were detected in an Image
Quant LAS4000 system (GE Healthcare) using an ECL kit.
2.6. 2-Deoxy-D-[1,2-3H]glucose ([3H]2DG) uptake
Basal glucose uptake was assessed as previously described
(Souza et al., 2013). Brieﬂy, the cells were rinsed once with HBSS
and then the medium was replaced with fresh DMEM/F12 1% FBS
for 2 h at 37 C. Astrocytes were incubated with DMEM/F12 1%FBS
containing 1 mCi/ml [3H]2DG for 20 min at 37 C. After incubation,
the cells were rinsed with HBSS and lysed overnight with NaOH
0.3 M. The incorporated radioactivity was measured in a scintilla-
tion counter. Cytochalasin B (10 mM) was used as a speciﬁc glucose
transporter inhibitor. Glucose uptake was determined by sub-
tracting the uptake in the presence of cytochalasin B from the total
uptake.
2.7. Glutamine synthetase activity
The enzymatic assay was performed as previously described
(Souza et al., 2013). Thirty days after the cultures reached conﬂu-
ence, the cell homogenate (0.1 mL e about 50 mg) was added to
0.1 mL of the reaction mixture containing (in mM): 10 MgCl2, 50 L-
glutamate, 100 imidazole-HCl buffer (pH 7.4), 10 2-mercaptoetha-
nol, 50 hydroxylamine-HCl and 10 ATP, and incubated for 15 min
(37 C). The reaction was stopped by the addition of 0.4 mL of a
solution containing (in mM): 370 ferric chloride, 670 HCl, and 200
trichloroacetic acid. After centrifugation, the absorbance of the
supernatant was measured at 530 nm and compared to the
absorbance generated using standard quantities of g-glutamylhy-
droxamate treated with the ferric chloride reagent. The results
were calculated as mmol/mg protein/h and expressed as the per-
centage of NB expression.
2.8. Glutathione content
GSH levels were assessed as previously described (Souza et al.,
Fig. 2. Changes in glucose uptake and GLUT1 expression in AIV cultures. Astrocytes
take up glucose. A) AD and AG astrocytes take up less glucose than NB astrocytes
(P < 0.05). B) NB astrocytes present higher GLUT1 expression (P < 0.01). The top of the
panel shows representative images of the blots. Data are presented as the mean þ S.E.
from 4 experimental trials performed in triplicate. NB ¼ newborn, AD ¼ adult and
AG ¼ aged.
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were homogenized (about 50 mg) and diluted in 100 mM sodium
phosphate buffer (pH 8.0) containing 5 mM EDTA, and the protein
was precipitated with 1.7% meta-phosphoric acid. The supernatant
was assayed with ophthaldialdehyde (1 mg/ml methanol) at room
temperature for 15 min. Fluorescence was measured using excita-
tion and emission wavelengths of 350 and 420 nm, respectively. A
calibration curve was performed with standard GSH solutions
(0e500 mM). The results were calculated as nmol GSH/mg protein
and expressed as the percentage of NB expression.
2.9. Protein assay
Protein content was measured using Lowry's method with
bovine serum albumin as a standard (Lowry et al., 1951).
2.10. Statistical analyses
Data were statistically analyzed using one-way analysis of
variance (ANOVA), followed by Tukey's test. P values < 0.05 were
considered signiﬁcant. For normality analyses, the Kolmogor-
oveSmirnov test was applied. All analyses were performed using
the Statistical Package for Social Sciences (SPSS) software version
15.0 (SPSS, Inc., Chicago, IL, USA).
3. Results
3.1. Adult and aged astrocytes exhibited changes in GFAP expression
levels
Despite being derived from animals of different ages, the
cultured astrocytes presented a speciﬁc morphology (Fig. 1A). As
shown by phase contrast microscopy, their shape varied from
polygonal to fusiform. Fig. 1B reveals that GFAP expression
decreased in an age-dependent manner in AD and AG astrocytes
compared to NB cultures (NB ¼ 100 ± 4.3%; AD ¼ 83.6 ± 2.8%;
AG ¼ 62.4 ± 5.3%; P < 0.01).
3.2. Adult and aged astrocytes take up less glucose and present
decreased expression of GLUT1
As shown in Fig. 2A, astrocytes of all ages take up glucose under
basal conditions; however, AD and AG astrocytes take up less
glucose than NB astrocytes (NB ¼ 100 ± 3.2%; AD ¼ 59.2 ± 7.4%;
AG¼ 47.6 ± 5.9%; P < 0.05). The absolute value obtained for glucose
uptake in the NB cells was 184.99 ± 5.91 fmol/mg protein and it was
considered 100%. As glucose uptake is primarily a function ofFig. 1. Cellular morphology and GFAP expression levels in AIV cultures. Astrocyte cultures pr
astrocytes presented decreased expression of GFAP (P < 0.01). The top of panel shows repres
trials performed in triplicate. NB ¼ newborn, AD ¼ adult and AG ¼ aged. Scale bar ¼ 50 mmGLUT1 in astrocytes; Fig. 2B shows that AD and AG astrocytes
exhibited decreased GLUT1 expression levels compared to that of
NB cultures (NB ¼ 100 ± 15%; AD ¼ 59.5 ± 9.6%; AG ¼ 46.8 ± 6.0%;
P < 0.01).3.3. Adult and aged astrocytes exhibited decreased GS activity and
increased GSH levels
Fig. 3A reveals that AD and AG astrocytes presented decreased
GS activity compared to that of NB (NB ¼ 100 ± 7.0%;
AD¼ 61.5 ± 5.5%; AG¼ 59.7 ± 2.7%; P < 0.01). AD and AG astrocytes
presented increased GSH content compared to that of NB
(NB ¼ 100 ± 2.6%; AD ¼ 117.4 ± 6.9%; AG ¼ 118.2 ± 3.6%; Fig. 3B,
P < 0.05). The absolute values obtained for GS activity and GSH
content assays in the NB cells were, respectively, 4.61 ± 0.32 mmol/
mg protein/h and 91.83 ± 3.8 nmol/mg protein and it were
considered 100%. Accordingly, we found increased expression of
the subunit xCT of system xc , (NB ¼ 100 ± 3.6%;
AD ¼ 402.5 ± 25.2%; 415.3 ± 31.3%; Fig. 3C, P < 0.01).esent a characteristic morphology by phase contrast. A) NB; B) AD; C) AG. D) AD and AG
entative images of the blots. Data are presented as the mean þ S.E. from 4 experimental
, magniﬁcation ¼ 200.
Fig. 3. Changes in glial functionality. A) GS activity was decreased in AD and AG as-
trocytes compared to that in NB astrocytes (P < 0.01). B) GSH content was increased in
AD and AG astrocytes compared with that in NB astrocytes (P < 0.05). C) xCT expression
was increased in AD and AG cells comparedwith NB cells (P< 0.01). The top of the panel
shows representative images of the blots. Data are presented as the mean þ S.E. from 4
experimental trials performed in triplicate. NB ¼ newborn, AD ¼ adult and AG ¼ aged.
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Aging causes a number of alterations in the properties of cells.
Although cerebral homeostasis is a tightly controlled process,
during aging, certain properties of this system may become
dysfunctional (Pertusa et al., 2007; Shen et al., 2014). Therefore, the
possibility to reliably study the features of the brain during
development and senescence has become a necessity, considering
the continuous increase in human lifespan and the concomitant
high incidence of neurodegenerative disorders. In this paper, we
proposed to simulate the aging process by extending the culture
time of astrocytes to 30 days after conﬂuence (AIV), and we have
shown that astrocyte primary cultures derived fromnewborn, adult
and aged Wistar rats show distinct metabolic properties.
Astrocytes are the most versatile cells in the CNS and are
fundamentally related to themaintenance of brain physiology. They
are involved in neurotransmitter management, ionic homeostasis,
and neuronal plasticity; in addition, they are located near the blood
vessels and participate in the bloodebrain barrier, enabling them to
manage the input of glucose and other substances into the brain
(Bellaver et al., 2014; Jiang and Cadenas, 2014; Perea et al., 2014;
Souza et al., 2013). In this sense, our group has previously shown
that astrocyte cultures from AD and AG Wistar rats are a reliable
tool to study brain development under physiological and patho-
logical conditions. Other studies using this methodology were
carried out at conﬂuence, but this is the ﬁrst study to analyze
cellular responses 30 days after conﬂuence, a condition that some
authors have suggested more closely mimics the process of aging
(Gottfried et al., 2002; Klamt et al., 2002). Authors have hypothe-
sized that primary dysfunction in astrocytes leads to compromisedfunctions in other cells, culminating in a loss of brain homeostasis
(Pertusa et al., 2007).
Morphological analysis of conﬂuent astrocyte cultures shows
that NB, AD and AG cells present a similar morphology. However,
NB cultures proliferate faster than AD and AG cultures. NB cells tend
to be much more plastic than AD and AG cells are, due to the fact
that they are placed in a developing tissue, hence, susceptible to
changes until reach maturity. Therefore, these adult astrocyte cul-
tures may truly represent developed and mature cells, allowing
them to respond more reliably to stimuli during the study of aging
models. Accordingly, the AIV model may represent an important
tool to study senescence. GFAP, an important astrocytic marker, is
related to migration and proliferation, glutamate transport and
glutamine synthesis (Middeldorp and Hol, 2011). In this sense, our
astrocyte cultures present intense GFAP expression (Fig. 1B). It is
noteworthy that herein, we evaluated GFAP under the same con-
ditions (AIV) but from rats of different ages.
One important property of these cells is that they take up
glucose, as they are in close contact with capillaries at their end-
feet processes (Benarroch, 2014). This is an essential activity
because it allows the astrocytes to synthesize glycogen and to
metabolize glucose into lactate for export to other cells e either to
use for their energy requirements or as a signalingmolecule (Dienel
and Cruz, 2014; Pellerin, 2005). We observed that AD and AG cells
take up less glucose than NB cells. This ﬁnding is in accordancewith
the fact that NB astrocytes present more stimuli to grow and pro-
liferate, requiring more energy generation and a consequent
greater need to take up energetic substrates until conﬂuence
(Kuzawa et al., 2014). In accordance with their higher glucose up-
take, the expression of glucose transporter 1 (GLUT 1) was also
higher in NB astrocytes compared to AD and AG astrocytes.
GS is an enzyme that is expressed only in astrocytes in the CNS,
and its activity tends to decrease with the aging process, as shown
by Bellaver et al., 2014. Herein, we found decreased GS activity in
AD and AG cells compared to that of NB cells. Astrocytes are key
cells in glutamate homeostasis, and a decrease in GS activity has
been reported in neuropsychiatric disorders, in which gluta-
matergic excitotoxicity plays an important role (Sheldon and
Robinson, 2007). Moreover, GS is markedly sensitive to oxidative
stress, which is increased under these conditions (Klamt et al.,
2002).
Notwithstanding, AD and AG astrocytes showed increased GSH
content compared to that of NB astrocytes. This ﬁnding is in
accordance with the ﬁndings of previous studies of cultured as-
trocytes aged in vitro, which showed that enzymatic antioxidant
defenses increased as aging occurred, probably stimulated by the
increase in reactive oxygen/nitrogen species generation (Klamt
et al., 2002). GSH synthesis is closely related to system xc
(Lewerenz et al., 2006). Therefore, we showed in Fig. 3C that AD and
AG astrocytes present augmented expression of the xCT subunit of
system xc , a cystine-glutamate antiporter that contributes both to
extracellular glutamatergic signaling and to the intracellular
availability of substrates to GSH synthesis; consequently, alter-
ations in this transporter may contribute to aging.
The complexity of the aging process depends on several vari-
ables, and in vitro conditions are very different from those in vivo.
Still, cell cultures remain a source of answers for the numerous
questions posed by researchers about brain function. This work
represents an innovative tool in the study of brain aging, because
astrocytic features are a key determinant of brain homeostasis. In
conclusion, we showed here that AD and AG astrocytes respond
differently compared with NB astrocytes in several respects, which
helps to elucidate the effect of astrocytes physiology on aging.
Taken together, our data suggest a role of astrocytes in senescence.
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